2023-09-242023-09-242017Bülbül, Y. vd. (2017). ''Assessment of palliative care in lung cancer in Turkey''. Medical Principles and Practice, 26(1), 50-56.1011-75711423-0151https://doi.org/10.1159/000452801https://karger.com/mpp/article/26/1/50/207403/Assessment-of-Palliative-Care-in-Lung-Cancer-inhttp://hdl.handle.net/11452/33997Çalışmada 43 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensuplarının girişleri yapılmıştır.Objective: To investigate the symptoms of lung cancer in Turkey and to evaluate approaches to alleviate these symptoms. Subjects and Methods: This study included 1,245 lung cancer patients from 26 centers in Turkey. Demographic characteristics as well as information regarding the disease and treatments were obtained from medical records and patient interviews. Symptoms were evaluated using the Edmonton Symptom Assessment Scale (ESAS) and were graded on a scale between 0 and 10 points. Data were compared using the. 2, Student t, and Mann-Whitney U tests. Potential predictors of symptoms were analyzed using logistic regression analysis. Results: The most common symptom was tiredness (n = 1,002; 82.1%), followed by dyspnea (n = 845; 69.3%), appetite loss (n = 801; 65.7%), pain (n = 798; 65.4%), drowsiness (n = 742; 60.8%), anxiety (n = 704; 57.7%), depression (n = 623; 51.1%), and nausea (n = 557; 45.5%). Of the 1,245 patients, 590 (48.4%) had difficulty in initiating or maintaining sleep. The symptoms were more severe in stages III and IV. Logistic regression analysis indicated a clear association between demographic characteristics and symptom distress, as well as between symptom distress (except nausea) and well-being. Overall, 804 (65.4%) patients used analgesics, 630 (51.5%) received treatment for dyspnea, 242 (19.8%) used enteral/parenteral nutrition, 132 (10.8%) used appetite stimulants, and 129 (10.6%) used anxiolytics/antidepressants. Of the 799 patients who received analgesics, 173 (21.7%) reported that their symptoms were under control, and also those on other various treatment modalities (dyspnea: 78/627 [12.4%], appetite stimulant: 25/132 [18.9%], and anxiolytics/antidepressants: 25/129 [19.4%]) reported that their symptoms were controlled. Conclusion: In this study, the symptoms progressed and became more severe in the advanced stages of lung cancer, and palliative treatment was insufficient in most of the patients in Turkey.eninfo:eu-repo/semantics/openAccessGeneral &iInternal medicineLung cancerPalliationPalliative treatmentSymptomsTreatmentQuality-of-lifeSleep disturbancesSymptom experienceSupportive carePainChemotherapyPrevalenceImpactAdultAgedAnalgesicsComorbidityDyspneaFatigueFemaleHumansInterviews as topicLogistic modelsLung neoplasmsMaleMiddle agedNeoplasm stagingNeoplasmsSquamous cellPainPalliative careQuality of LifeTurkeyArticle0003914571000082-s2.0-84992688577505626127780164Medicine, general & internalChildhood Cancer Survivor; Sleep Disorders; Breast NeoplasmsAntidepressant agentAnxiolytic agentAppetite stimulantBisphosphonic acid derivativeBronchodilating agentCyproheptadineFentanylMegestrol acetateMorphineNonsteroid antiinflammatory agentParacetamolSedative agentTramadolVitaminAnalgesic agentAdultAnalgesiaAnxiety disorderArticleBone metastasisCachexiaCancer fatigueCancer painCancer palliative therapyCancer patientCancer radiotherapyCombination drug therapyComparative studyControlled studyDepressionDrowsinessDysphagiaDyspneaEdmonton symptom assessment scaleFemaleHumanLoss of appetiteLung cancerMajor clinical studyMaleMiddle agedNasogastric tubeNauseaNebulizerNoninvasive ventilationDisease severityNutritional supportOxygen therapyPain severityParenteral nutritionPercutaneous endoscopic gastrostomyPleurodesisProspective studyPsychopharmacotherapySleep disorderStentSymptom assessmentThoracocentesisTurkey (republic)Vitamin supplementationWellbeingAgedCancer stagingComplicationDyspneaFatigueInterviewLung neoplasmsPainPalliative therapyPsychologyQuality of lifeSquamous cell carcinomaStatistical modelTurkeyComorbidity